✓ No active regulatory warningsFDA MedWatch, EMA EudraVigilance, WHO VigiBase, WADA Prohibited List · 2026-05-29
📰Read the full White Willow Bark evidence review on GMJ News →Complete clinical article, references and updates on news.gmj.ge. This page is the structured safety summary.⚠ Patient substituting willow bark for cardiac aspirin — does NOT reliably inhibit platelet COX-1 [1]
⚠ Aspirin-allergic patient using willow bark — cross-reactivity expected [1]
⚠ Pregnant patient using willow bark — contraindicated (salicylate) [1]
⚠ Child with fever/viral illness given willow bark — theoretical Reye syndrome risk [1]
ℹ️ Not obtained from food. Not applicable — this is not obtained from food in meaningful amounts; supplementation is the practical route.
🔬 Lab interpreter
Recommended test
No routine monitoring for short-term use
No routine monitoring for short-term use
Reference range / target
N/A
N/A
When to test
N/A
N/A
Monitor INR if on warfarin [1].
Full lab monitoring ↓⚕ For professionals — confirm ranges against your local laboratory.
Clinical verdict
Willow bark is NOT 'natural aspirin' — different metabolism, different platelet effects, additional polyphenol mechanisms. Its strongest evidence is for low back pain (240 mg salicin/day ≈ rofecoxib 12.5 mg in RCT). Key clinical rules: (1) do NOT substitute for prescribed cardiac aspirin; (2) aspirin-allergic patients must avoid; (3) contraindicated in pregnancy and children with viral illness; (4) onset is 1–2 weeks, not hours [1] [2].
1 How much do I need?
👤 Adults: Specific dosage data under clinical review
👴 Elderly: Specific dosage data under clinical review
🤰 Pregnancy: See guidance
Contraindicated. Salicylates cross the placenta. Same concerns as aspirin [1].
👦 Pediatric: See guidance
Avoid in children with viral illness — same theoretical Reye syndrome risk as aspirin (though not documented with willow bark specifically). No pediatric studies [1].
🏃 Athletes: Standard dose
⚖️ Obesity: Standard dose
Fat-soluble compounds may require dose adjustment in obesity.
🩺 Renal: Consult specialist
Dose adjustment may be needed in renal impairment.
🌱 Vegan: Standard dose
How to take
🍽 Timing: BID with food [1].
💊 With food: With food to reduce GI irritation [1].
🚫 Avoid: In aspirin-allergic patients. During pregnancy. In children with viral illness. As cardiac aspirin substitute [1].
2 Which form?
| Form | Bioavailability | Vegan | Cost |
|---|---|---|---|
| ['Willow bark extract (standardized to salicin)', 'preferred', 'Standardized to 15–25% salicin. 240 mg salicin/day (split BID). Clinical evidence uses this form [1].'] | Standard | Check label | |
| ['Dried willow bark (tea)', 'traditional', '1–3 g bark simmered 10 min. Lower salicin content. Sub-therapeutic for pain [1].'] | Standard | Check label | |
| ['Willow bark tincture', 'traditional', '1–2 mL TID. Variable salicin content [1].'] | Standard | Check label |
3 Common questions
Is willow bark the same as taking aspirin? ▼
No. Willow bark provides salicin (metabolized to salicylic acid); aspirin is acetylsalicylic acid. Key differences: (1) aspirin irreversibly inhibits platelet COX-1 — willow bark does not reliably do this; (2) aspirin has rapid onset — willow bark takes 1–2 weeks; (3) willow bark contains additional polyphenols that may contribute to anti-inflammatory effects beyond COX. Do NOT substitute willow bark for prescribed aspirin [1].
Can I use willow bark instead of ibuprofen? ▼
For mild-to-moderate low back pain, 240 mg salicin/day has RCT evidence comparable to a COX-2 inhibitor. It may be a reasonable alternative for chronic musculoskeletal pain in patients who want to avoid NSAIDs. However, onset is slower (1–2 weeks vs hours), and it should not replace NSAIDs for acute severe pain [1] [2].
Is willow bark safer than NSAIDs for the stomach? ▼
Probably somewhat. Willow bark has lower GI toxicity than traditional NSAIDs in clinical trials, likely because salicin is a prodrug absorbed from the intestine and metabolized systemically (less direct gastric mucosal irritation). However, it is not GI-risk-free [1].
Can I take willow bark if I'm allergic to aspirin? ▼
No. Cross-reactivity is expected. Patients with aspirin allergy (including aspirin-exacerbated respiratory disease) should avoid willow bark due to salicylate content [1].
4 Clinical evidence
Strong
Low back pain: a landmark RCT (n=228) compared willow bark extract (240 mg salicin/day) with rofecoxib 12.5 mg and placebo for acute low back pain exacerbation. Willow bark was comparable to rofecoxib and significantly better than placebo for pain-free days [2]. HIGH
Moderate
Low back pain (dose-response): another RCT found 240 mg/day salicin was effective but 120 mg/day was not significantly better than placebo — establishing a dose threshold [2]. Osteoarthritis: 2 small RCTs with mixed results. One 6-week trial showed modest pain improvement vs placebo [1]. Reduced rescue medication: willow bark users reduced NSAID/analgesic use in several studies [1]. MODERATE
Insufficient
Headache/migraine: traditional use; no RCTs [1]. Rheumatoid arthritis: 1 pilot study; insufficient [1]. Fever: traditional antipyretic use; no modern studies (paracetamol is standard) [1]. Cardiovascular prophylaxis: willow bark does NOT reliably inhibit platelet COX-1 and should not replace aspirin for cardiac prophylaxis [1]. LOW
5 Safety, toxicity & adverse events
Absolute contraindications
✕ Salicylate/aspirin allergy
✕ Children/teens with viral illness — Reye's syndrome risk (salicylate)
✕ Active peptic ulcer or bleeding disorder
Relative
⚠ Anticoagulants/antiplatelets — additive bleeding risk
⚠ Asthma with aspirin sensitivity
⚠ Gout (salicylate affects urate); discontinue before surgery
🚩 Red flags
● Patient with aspirin allergy using willow bark — cross-reactivity [1]
● Patient replacing cardiac aspirin with willow bark — inadequate platelet inhibition [1]
● Pregnant patient using willow bark — contraindicated [1]
● Tinnitus in patient using high-dose willow bark — salicylate toxicity signal [1]
6 Interactions
Drug interactions
Warfarin / Anticoagulants Major
Mechanism: Salicylate antiplatelet activity + protein binding displacement [1].
Effect: Increased bleeding risk [1].
Action: Monitor INR. Avoid combination if possible [1].
Methotrexate Major
Mechanism: Salicylates reduce renal clearance of methotrexate [1].
Effect: Methotrexate toxicity (bone marrow suppression, hepatotoxicity) [1].
Action: Avoid combination [1].
Supplement synergies
Boswellia · Standard doses of each
Complementary anti-inflammatory: willow bark (COX) + boswellia (5-LOX). Dual pathway inhibition [1].
Complementary anti-inflammatory: willow bark (COX) + boswellia (5-LOX). Dual pathway inhibition [1].
Devil's Claw · Standard doses of each
Traditional European combination for musculoskeletal pain [1].
Traditional European combination for musculoskeletal pain [1].
7 Regulatory
Germany (Commission E): Approved for fever, pain, rheumatic complaints [1].
European Union (EMA): Well-established use for low back pain. Traditional use for minor joint pain, fever, headache [1].
United States (FDA): Available as dietary supplement. No FDA-approved claims [1].
European Pharmacopoeia: Willow bark (Salicis cortex) monograph with salicin content specifications [1].
8 Cite this page
Vancouver: Pkhakadze G. White Willow Bark — safety profile [Internet]. Tbilisi: PHIG; 2026 [cited 2026 Aug 15]. Available from: https://supplement.ge/ingredients/white-willow-bark/
APA 7th: Pkhakadze, G. (2026). White Willow Bark — Safety profile. Public Health Institute of Georgia. https://supplement.ge/ingredients/white-willow-bark/
📋 Editorial information
Author: Prof. G. Pkhakadze, MD, MPH, PhD
Institution: Public Health Institute of Georgia (PHIG)
Affiliation: David Tvildiani Medical University (DTMU)
First published: January 2026
Last reviewed: 2026-05-29
Next review: February 2027
References: 4 cited sources
COI: SupplementIndex receives no funding from supplement manufacturers. All content independently authored by PHIG.
Process: Systematic literature review
📄 License & reuse
Published under Creative Commons Attribution 4.0 International (CC BY 4.0). You may share and adapt for any purpose with attribution.
Pkhakadze G. "White Willow Bark — Safety Profile." SupplementIndex, PHIG, 2026. https://supplement.ge/ingredients/white-willow-bark/ CC BY 4.0.
GP
Prof. G. Pkhakadze, MD, MPH, PhD
Professor of Public Health · Head of Department, DTMU
Editor-in-Chief, Georgian Medical Journal (ISSN 3088-4322)
Chair, Public Health Institute of Georgia · UEMS Public Health Section
Educational and public health purposes. CC BY 4.0. Consult your healthcare provider before starting any supplement. Corrections: info@accreditation.ge. Publisher: PHIG